Cargando…
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
Integrative database analysis was performed to identify novel candidate oncogene AHNAK2 overexpressed in clear cell renal cell carcinoma (ccRCC). However, the function of AHNAK2 in cancer cells is currently unknown. In this study, we first confirmed the upregulation of AHNAK2 in ccRCC tissues compar...
Autores principales: | Wang, Minglei, Li, Xuefeng, Zhang, Jin, Yang, Qiong, Chen, Wenqi, Jin, Weilin, Huang, Yi-Ran, Yang, Ru, Gao, Wei-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399579/ https://www.ncbi.nlm.nih.gov/pubmed/28435451 http://dx.doi.org/10.7150/thno.18198 |
Ejemplares similares
-
AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013) -
AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017) -
The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022) -
Ubiquitin ligase SMURF1 functions as a prognostic marker and promotes growth and metastasis of clear cell renal cell carcinoma
por: Ke, Mang, et al.
Publicado: (2017) -
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021)